Clinical Trials Logo

Autoimmune Haemolytic Anaemia clinical trials

View clinical trials related to Autoimmune Haemolytic Anaemia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04269551 Completed - Clinical trials for Autoimmune Haemolytic Anaemia

A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease

Start date: June 15, 2020
Phase: Phase 1
Study type: Interventional

Primary Objective: To assess the safety and tolerability in participants with cold agglutinin disease (CAD), after a single dose of intravenous (IV) BIVV020 Secondary Objectives: To assess, in participants with cold agglutinin disease, after a single dose of intravenous (IV) BIVV020: - The effect of BIVV020 on complement mediated hemolysis - The pharmacodynamics (PD) of BIVV020 relating to complement inhibition - The pharmacokinetics (PK) of BIVV020 - The immunogenicity of BIVV020

NCT ID: NCT04070612 Completed - Cytopenia Clinical Trials

National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.

BIOCEREVANCE
Start date: April 4, 2007
Phase:
Study type: Observational

This study aims to study prospectively the clinical and paraclinical evolution and prognostic factors of autoimmune haemolytic anemias, Evans syndromes and chronic immunological thrombocytopenic purpura of children in France.